164 related articles for article (PubMed ID: 16906584)
21. MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.
Marquez ME; Deglesne PA; Suarez G; Romano E
Int J Lab Hematol; 2011 Apr; 33(2):194-200. PubMed ID: 20942870
[TBL] [Abstract][Full Text] [Related]
22. ZAP-70 expression is low in normal precursor B cells or hematogones.
Davis BH; Schwartz M
Cytometry B Clin Cytom; 2006 Jul; 70(4):315-9. PubMed ID: 16906572
[TBL] [Abstract][Full Text] [Related]
23. Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory.
Gibbs G; Bromidge T; Howe D; Hopkins J; Johnson S
Clin Lab Haematol; 2005 Aug; 27(4):258-66. PubMed ID: 16048494
[TBL] [Abstract][Full Text] [Related]
24. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells.
Rizzo D; Bouvier G; Youlyouz-Marfak I; Guerin E; Trimoreau F; Bordessoule D; Jaccard A; Gachard N; Feuillard J
Cytometry B Clin Cytom; 2013 Mar; 84(2):125-32. PubMed ID: 23225571
[TBL] [Abstract][Full Text] [Related]
25. Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells.
Smolej L; Vroblova V; Motyckova M; Jankovicova K; Schmitzova D; Krejsek J; Maly J
Neoplasma; 2011; 58(2):140-5. PubMed ID: 21275464
[TBL] [Abstract][Full Text] [Related]
26. Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.
Kern W; Dicker F; Schnittger S; Haferlach C; Haferlach T
Cytometry B Clin Cytom; 2009 Nov; 76(6):385-93. PubMed ID: 19479984
[TBL] [Abstract][Full Text] [Related]
27. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
28. National standardization of ZAP-70 determination by flow cytometry: the French experience.
Le Garff-Tavernier M; Ticchioni M; Brissard M; Salmon C; Raynaud S; Davi F; Bernard A; Merle-Béral H; Ajchenbaum-Cymbalista F; Letestu R
Cytometry B Clin Cytom; 2007 Mar; 72(2):103-8. PubMed ID: 17041946
[TBL] [Abstract][Full Text] [Related]
29. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia.
Wiestner A
Cytometry B Clin Cytom; 2006 Jul; 70(4):201-3. PubMed ID: 16906579
[TBL] [Abstract][Full Text] [Related]
31. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
Cytometry B Clin Cytom; 2006 Jul; 70(4):209-13. PubMed ID: 16906583
[No Abstract] [Full Text] [Related]
33. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
35. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
37. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
[TBL] [Abstract][Full Text] [Related]
38. ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
Marti G; Orfao A; Goolsby C
Cytometry B Clin Cytom; 2006 Jul; 70(4):197-200. PubMed ID: 16906575
[No Abstract] [Full Text] [Related]
39. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
[TBL] [Abstract][Full Text] [Related]
40. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]